Clinician-parent communication during informed consent for pediatric leukemia trials
- PMID: 15784918
- DOI: 10.1093/jpepsy/jsi032
Clinician-parent communication during informed consent for pediatric leukemia trials
Abstract
Objective: To address the need to describe informed consent in pediatric settings and to identify barriers to parent understanding, this study assessed how aspects of clinician-parent communication during the informed consent conference (ICC) relate to parent understanding of informed consent and parent perception of the impact of the ICC on their anxiety and control.
Methods: Parents of 127 children with newly diagnosed leukemia who were eligible for clinical trials were the participants. The study used comprehensive methods including both observational and self-report assessment methods.
Results: Structural equation modeling demonstrated that parent race and socioeconomic status (SES) were powerful predictors of clinician-parent communication, parent anxiety and control as a result of the ICC, and parent understanding. Clinician information giving and partnership building predicted parent participation during the ICC.
Conclusions: These findings may be used to design interventions that increase the effectiveness of the ICC by identifying specific elements of the conference that influence parent affect and understanding.
Comment in
-
Commentary: SES, ethnicity and goodness-of-fit in clinician-parent communication during pediatric cancer trials.J Pediatr Psychol. 2005 Apr-May;30(3):231-4. doi: 10.1093/jpepsy/jsi033. Epub 2005 Feb 23. J Pediatr Psychol. 2005. PMID: 15784919 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
